Business Description
Australian Clinical Labs Ltd
ISIN : AU0000148496
Description
Australian Clinical Labs, or ACL, is Australia's third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.08 | |||||
Equity-to-Asset | 0.28 | |||||
Debt-to-Equity | 1.98 | |||||
Debt-to-EBITDA | 2.13 | |||||
Interest Coverage | 7.33 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.47 | |||||
Beneish M-Score | -3.66 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Book Growth Rate | 54.2 | |||||
Future 3-5Y Total Revenue Growth Rate | 2.77 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.01 | |||||
9-Day RSI | 57.42 | |||||
14-Day RSI | 57.92 | |||||
6-1 Month Momentum % | -21.33 | |||||
12-1 Month Momentum % | -34.21 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.66 | |||||
Quick Ratio | 0.57 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 47.72 | |||||
Days Sales Outstanding | 37.85 | |||||
Days Payable | 95.83 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.95 | |||||
Dividend Payout Ratio | 1.56 | |||||
Forward Dividend Yield % | 3.95 | |||||
5-Year Yield-on-Cost % | 3.97 | |||||
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | -1.7 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 81 | |||||
Operating Margin % | 5.32 | |||||
Net Margin % | 2.33 | |||||
FCF Margin % | 22.13 | |||||
ROE % | 9.04 | |||||
ROA % | 2.63 | |||||
ROIC % | 3.85 | |||||
ROC (Joel Greenblatt) % | 9.42 | |||||
ROCE % | 7.11 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 32.86 | |||||
Forward PE Ratio | 12.55 | |||||
PE Ratio without NRI | 28.11 | |||||
PS Ratio | 0.77 | |||||
PB Ratio | 3.08 | |||||
Price-to-Free-Cash-Flow | 3.47 | |||||
Price-to-Operating-Cash-Flow | 3.31 | |||||
EV-to-EBIT | 28.84 | |||||
EV-to-Forward-EBIT | 10.24 | |||||
EV-to-EBITDA | 5.29 | |||||
EV-to-Forward-EBITDA | 4.06 | |||||
EV-to-Revenue | 1.23 | |||||
EV-to-Forward-Revenue | 1.14 | |||||
EV-to-FCF | 5.54 | |||||
Earnings Yield (Greenblatt) % | 3.47 | |||||
FCF Yield % | 28.75 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Australian Clinical Labs Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | 663.423 | ||
EPS (TTM) (A$) | 0.077 | ||
Beta | 1.54 | ||
Volatility % | 33.87 | ||
14-Day RSI | 57.92 | ||
14-Day ATR (A$) | 0.075922 | ||
20-Day SMA (A$) | 2.5095 | ||
12-1 Month Momentum % | -34.21 | ||
52-Week Range (A$) | 2.14 - 3.41 | ||
Shares Outstanding (Mil) | 201.83 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Australian Clinical Labs Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Australian Clinical Labs Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
Australian Clinical Labs Ltd Frequently Asked Questions
What is Australian Clinical Labs Ltd(ASX:ACL)'s stock price today?
The current price of ASX:ACL is A$2.53. The 52 week high of ASX:ACL is A$3.41 and 52 week low is A$2.14.
When is next earnings date of Australian Clinical Labs Ltd(ASX:ACL)?
The next earnings date of Australian Clinical Labs Ltd(ASX:ACL) is 2024-08-22 Est..
Does Australian Clinical Labs Ltd(ASX:ACL) pay dividends? If so, how much?
The Dividend Yield %  of Australian Clinical Labs Ltd(ASX:ACL) is 3.95% (As of Today), Highest Dividend Payout Ratio of Australian Clinical Labs Ltd(ASX:ACL) was 2.68. The lowest was 0.14. And the median was 1.41. The  Forward Dividend Yield % of Australian Clinical Labs Ltd(ASX:ACL) is 3.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |